The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Non‐invasive biomarkers for immunotherapy response remain a compelling unmet medical need. POLARIS‐03 is a multicenter phase II trial to evaluate the safety and efficacy of toripalimab (anti‐programmed cell death 1) in refractory metastatic urothelial carcinoma (mUC). We assessed the predictive utility of longitudinal circulating tumor DNA (ctDNA) analysis from a single‐institution biomarker cohort...
ObjectivesTo report the perioperative outcomes of robot‐assisted radical cystectomy and elucidate their risk factors.MethodsA review of the Asian Robot‐Assisted Radical Cystectomy Consortium database from 2007 to 2020 was performed. The perioperative outcomes studied included complication rates, time to solid food intake, estimated blood loss, length of hospital stay, and 30‐day readmission rates...